Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Incyte Corporation INCY

Healthcare  —  Biotechnology
123.20 (1.62) (1.30%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Incyte Corporation (INCY) P/B ratio

As of 28 September 2026, Incyte Corporation (INCY) trades at a P/B ratio of 3.9×. Over the past ten years it has ranged from 0.0× (June 2015) to 426× (September 2015); the current reading is higher than 27% of that period. That is above the Biotechnology industry median of 2.6× and above the Healthcare sector median of 2.6×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 3.7× (10.08%)
FY2024 4.1× 47.13%
FY2023 2.8× (30.21%)
FY2022 4.0× (5.83%)
FY2021 4.3× (40.92%)
FY2020 7.3× 0.58%
FY2019 7.2× 2.99%
FY2018 7.0× (44.60%)
FY2017 12.7× (72.38%)
FY2016 45.8× (59.73%)

Quarterly

Period P/B ratio Change
Jun 2026 3.6× 7.30%
Mar 2026 3.3× (10.57%)
Dec 2025 3.7× 4.57%
Sep 2025 3.6× 12.64%
42 more quarters

Against its own ten years

Low 0.0× High 426×
Ten-year median 6.3×
Current reading's percentile 27

P/B ratio against peers

Company P/B ratio
BNTX BioNTech SE Sponsored ADR compare 1.2×
RPRX Royalty Pharma PLC compare 2.7×
JAZZ Jazz Pharmaceuticals PLC compare 3.1×
GMAB Genmab A/S Sponsored ADR compare 3.6×
INCY Incyte Corporation 3.9×
ROIV Roivant Sciences Ltd. compare 5.4×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 7.9×
ALNY Alnylam Pharmaceuticals, Inc. compare 25.2×
INSM Insmed, Inc. compare 33.8×
Biotechnology industry median 2.6×
Healthcare sector median 2.6×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on INCY